secwatch.observer — SEC 8-K summary
======================================

Issuer:     TuHURA Biosciences, Inc./NV (HURA)
CIK:        0001498382
Form:       8-K
Filed at:   2024-09-25T23:59:59+00:00
Accession:  0000950170-24-109377
Event type: m_and_a
Sentiment:  positive
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kintara and TuHURA waive two stockholder approval conditions for merger; reverse split condition added
--------------------------------------------------------------------------------

- TuHURA waives requirement for Kintara stockholder vote on reincorporation from Nevada to Delaware.
- Authorized share increase vote waived conditional on Kintara effecting a reverse stock split of 1-for-35 or greater.
- Waiver Agreement dated September 25, 2024, does not alter other Merger Agreement terms.
- Kintara previously filed a definitive proxy/prospectus for the merger (S-4 effective August 13, 2024).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1498382/000095017024109377/0000950170-24-109377-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1498382/000095017024109377/ktra-20240925.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-109377

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer